Neurocrine Biosciences
NBIX
#1285
Rank
NZ$30.52 B
Marketcap
NZ$303.63
Share price
0.93%
Change (1 day)
38.29%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Quarterly Reports

Thumbnail Neurocrine Biosciences
 Quarterly Report 2026-q1

Quarterly Report 2026-q1

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences
 Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences
 Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences
 Quarterly Report 2025-q1

Quarterly Report 2025-q1

Language: English

View Quarterly Report